NASDAQ:RARE - Ultragenyx Pharmaceutical News Headlines

$60.37
+3.21 (+5.62 %)
(As of 06/17/2019 01:25 PM ET)
Today's Range
$57.56
Now: $60.37
$60.61
50-Day Range
$54.93
MA: $61.13
$68.63
52-Week Range
$37.44
Now: $60.37
$90.98
Volume12,924 shs
Average Volume356,707 shs
Market Capitalization$3.47 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.19

Headlines

Ultragenyx Pharmaceutical (NASDAQ RARE) News Headlines

Source:
DateHeadline
Ultragenyx Expands Leadership Team and Promotes Erik Harris to Chief Commercial OfficerUltragenyx Expands Leadership Team and Promotes Erik Harris to Chief Commercial Officer
finance.yahoo.com - June 17 at 8:35 AM
Ultragenyx Pharmaceutical (RARE) Presents At Goldman Sachs 40th Annual Global Healthcare Conference - SlideshowUltragenyx Pharmaceutical (RARE) Presents At Goldman Sachs 40th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - June 15 at 12:23 AM
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Receives Consensus Rating of "Buy" from AnalystsUltragenyx Pharmaceutical Inc (NASDAQ:RARE) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - June 11 at 6:35 AM
$21.54 Million in Sales Expected for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) This Quarter$21.54 Million in Sales Expected for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) This Quarter
www.americanbankingnews.com - June 9 at 4:52 AM
Zacks: Brokerages Anticipate Ultragenyx Pharmaceutical Inc (RARE) Will Post Earnings of -$1.73 Per ShareZacks: Brokerages Anticipate Ultragenyx Pharmaceutical Inc (RARE) Will Post Earnings of -$1.73 Per Share
www.americanbankingnews.com - June 7 at 4:10 AM
Ultragenyx (RARE) Down 5.7% Since Last Earnings Report: Can It Rebound?Ultragenyx (RARE) Down 5.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 5 at 6:57 PM
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIOs 2019 Henri A. Termeer Biotechnology Visionary AwardUltragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO's 2019 Henri A. Termeer Biotechnology Visionary Award
www.marketwatch.com - May 29 at 6:57 PM
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary AwardUltragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award
finance.yahoo.com - May 29 at 6:57 PM
Is Ultragenyx Pharmaceutical Inc.s (NASDAQ:RARE) CEO Paid At A Competitive Rate?Is Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) CEO Paid At A Competitive Rate?
finance.yahoo.com - May 23 at 7:25 PM
Is Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) CEO Paid At A Competitive Rate?Is Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) CEO Paid At A Competitive Rate?
finance.yahoo.com - May 23 at 7:25 PM
Ultragenyx to Present at Bank of America Merrill Lynch Healthcare ConferenceUltragenyx to Present at Bank of America Merrill Lynch Healthcare Conference
finance.yahoo.com - May 10 at 6:54 PM
Edited Transcript of RARE earnings conference call or presentation 6-May-19 9:00pm GMTEdited Transcript of RARE earnings conference call or presentation 6-May-19 9:00pm GMT
finance.yahoo.com - May 7 at 7:00 PM
Ultragenyx Pharmaceutical Inc (RARE) Q1 2019 Earnings Call TranscriptUltragenyx Pharmaceutical Inc (RARE) Q1 2019 Earnings Call Transcript
www.fool.com - May 7 at 2:06 AM
Ultragenyx Reports First Quarter 2019 Financial Results and Corporate UpdateUltragenyx Reports First Quarter 2019 Financial Results and Corporate Update
www.globenewswire.com - May 6 at 7:39 PM
Ultragenyx Pharmaceutical Q1 Earnings PreviewUltragenyx Pharmaceutical Q1 Earnings Preview
seekingalpha.com - May 6 at 8:23 AM
What's in Store for Catalyst Pharma (CPRX) Q1 Earnings?What's in Store for Catalyst Pharma (CPRX) Q1 Earnings?
finance.yahoo.com - May 3 at 7:14 PM
Protalix (PLX) to Report Q1 Earnings: What's in the Cards?Protalix (PLX) to Report Q1 Earnings: What's in the Cards?
finance.yahoo.com - May 2 at 7:59 PM
RARE Makes Notable Cross Below Critical Moving AverageRARE Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - May 1 at 7:28 PM
Did Hedge Funds Drop The Ball On Ultragenyx Pharmaceutical Inc (RARE) ?Did Hedge Funds Drop The Ball On Ultragenyx Pharmaceutical Inc (RARE) ?
finance.yahoo.com - May 1 at 7:28 PM
Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate UpdateUltragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate Update
finance.yahoo.com - April 30 at 6:52 PM
Ultragenyx nabs accelerated review status in U.S. for UX007 for LC-FAODUltragenyx nabs accelerated review status in U.S. for UX007 for LC-FAOD
seekingalpha.com - April 16 at 7:44 PM
Company on Track to Submit NDA to FDA in Mid-2019Company on Track to Submit NDA to FDA in Mid-2019
www.globenewswire.com - April 16 at 7:44 PM
Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation DisordersUltragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders
finance.yahoo.com - April 16 at 7:44 PM
Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New YorkUltragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York
finance.yahoo.com - April 11 at 9:14 AM
Folks with rare diseases find support at Liberty Science Center expoFolks with rare diseases find support at Liberty Science Center expo
www.msn.com - March 31 at 8:16 AM
Have Insiders Been Selling Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares?Have Insiders Been Selling Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares?
finance.yahoo.com - March 27 at 8:27 AM
Ultragenyx Announces Approval of Crysvita(R) (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and ChildrenUltragenyx Announces Approval of Crysvita(R) (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
www.marketwatch.com - March 26 at 7:43 PM
Ultragenyxs Crysvita OKd in BrazilUltragenyx's Crysvita OK'd in Brazil
seekingalpha.com - March 26 at 7:43 PM
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and ChildrenUltragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children
www.globenewswire.com - March 26 at 8:32 AM
New Research Coverage Highlights UnitedHealth Group, Ultragenyx Pharmaceutical, Navistar International, REGENXBIO, Par Pacific, and Athenex — Consolidated Revenues, Company Growth, and Expectations for 2019New Research Coverage Highlights UnitedHealth Group, Ultragenyx Pharmaceutical, Navistar International, REGENXBIO, Par Pacific, and Athenex — Consolidated Revenues, Company Growth, and Expectations for 2019
finance.yahoo.com - March 26 at 8:32 AM
Why Is Ultragenyx (RARE) Up 12.4% Since Last Earnings Report?Why Is Ultragenyx (RARE) Up 12.4% Since Last Earnings Report?
finance.yahoo.com - March 21 at 7:48 PM
ULTRAGENYX PHARMACEUTICAL INC. RARE Files An 8-K Results of Operations and Financial ConditionULTRAGENYX PHARMACEUTICAL INC. RARE Files An 8-K Results of Operations and Financial Condition
www.marketwatch.com - March 15 at 8:31 AM
National Organization for Rare Disorders (NORD) “ Announces 2019 Rare Impact Award HonoreesNational Organization for Rare Disorders (NORD) “ Announces 2019 Rare Impact Award Honorees
www.marketwatch.com - March 12 at 10:48 PM
Biotech Investors Celebrating Deal Boom Can Thank Rough Quarter - BloombergBiotech Investors Celebrating Deal Boom Can Thank Rough Quarter - Bloomberg
www.bloomberg.com - March 11 at 7:33 AM
RARE Makes Bullish Cross Above Critical Moving AverageRARE Makes Bullish Cross Above Critical Moving Average
www.nasdaq.com - March 1 at 7:04 PM
Ultragenyx prices stock offering at $60Ultragenyx prices stock offering at $60
seekingalpha.com - February 27 at 8:21 AM
Ultragenyx Announces Pricing of Public Offering of Common StockUltragenyx Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 27 at 8:21 AM
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type IaUltragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
finance.yahoo.com - February 22 at 8:23 AM
Ultragenyx Pharmaceutical Inc. 2018 Q4 - Results - Earnings Call Slides - Seeking AlphaUltragenyx Pharmaceutical Inc. 2018 Q4 - Results - Earnings Call Slides - Seeking Alpha
seekingalpha.com - February 21 at 6:59 PM
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia - GlobeNewswireUltragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia - GlobeNewswire
globenewswire.com - February 21 at 6:59 PM
Ultragenyx Pharmaceutical Inc (RARE) Q4 2018 Earnings Conference Call Transcript - Motley FoolUltragenyx Pharmaceutical Inc (RARE) Q4 2018 Earnings Conference Call Transcript - Motley Fool
www.fool.com - February 21 at 6:59 PM
Here's Why This Small Biotech Stock Just Hit A Four-Month HighHere's Why This Small Biotech Stock Just Hit A Four-Month High
finance.yahoo.com - February 20 at 6:50 PM
Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4
www.zacks.com - February 20 at 8:26 AM
Edited Transcript of RARE earnings conference call or presentation 19-Feb-19 10:00pm GMTEdited Transcript of RARE earnings conference call or presentation 19-Feb-19 10:00pm GMT
finance.yahoo.com - February 20 at 8:26 AM
Ultragenyx Pharmaceutical Inc (RARE) Q4 2018 Earnings Conference Call TranscriptUltragenyx Pharmaceutical Inc (RARE) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 20 at 3:05 AM
Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update - GlobeNewswireUltragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update - GlobeNewswire
globenewswire.com - February 19 at 7:01 PM
Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate UpdateUltragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update
finance.yahoo.com - February 19 at 7:01 PM
Ultragenyx: 4Q Earnings SnapshotUltragenyx: 4Q Earnings Snapshot
finance.yahoo.com - February 19 at 7:01 PM
Ultragenyx CMO helms rare disease team - San Francisco Business TimesUltragenyx CMO helms rare disease team - San Francisco Business Times
www.bizjournals.com - February 14 at 6:25 PM
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update - GlobeNewswireUltragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update - GlobeNewswire
globenewswire.com - February 14 at 6:25 PM
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel